Anton Pil

The Last Word: Anton Pil of JPMorgan Chase on the Impact of Drugs Like Ozempic on People’s Spending Patterns

by | Jan 19, 2024
“GLP-1 drugs, medications like Ozempic and other weight-loss drugs that are actually diabetes drugs, provide me with retail insights,” said Pil, according to a takeaway featured in D CEO. “We can look through Chase’s anonymized data by individual—we bank more than 95 million individuals in this country—and I can identify people who are on Ozempic based on their spending patterns."
MORE